We see global equities entering 2026 with supportive momentum, but a higher bar for results. Investor scrutiny is rising, ...

Platform now available to pharmaceutical research partners; powers collaborations totaling over $200 million SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery ...

Risk-free rates are much lower than in 2000, supporting higher equity valuations without replicating past bubble dynamics.

VB Desai Fin Share: compare VB Desai Fin with up to two competing stocks only on Moneycontrol. Use our stock comparison tool to check price, market cap, returns & more ...

US appeals court appears skeptical of Meta, social media companies' bid to cut off addiction lawsuits A U.S. appeals court on Tuesday appeared inclined to allow lawsuits alleging major social media ...

Vivo Biotech Share: compare Vivo Biotech with up to two competing stocks only on Moneycontrol. Use our stock comparison tool to check price, market cap, returns & more ...